// App-Quantinova.ai

OR4‐020 : Patient perceptions on the symptomatic and economic burden of myeloproliferative neoplasms

Researchers

Presenter

  • C Harrison

Principal Investigators

  • Z Pemberton-Whiteley

  • S Ali

  • F Wadelin

  • J Mathias

  • C Thomas

  • M Campbell-Drew

  • J Waller

  • G Taylor-Stokes

  • A Ducs

  • B Taylor

Medical Centers

  • NHS Foundation, Guy's and St. Thomas's Hospital, London

  • Leukaemia CARE, Worcester

  • Hull Royal Infirmary, Hull, UK

  • NHS Trust, Nottingham University Hospitals, Nottingham

  • MPN Voice, London

  • Adelphi Real World, Maccelsfield, UK

  • Novartis UK, Camberley, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A